Bayer buys Merck's consumer business for $14.2B
In the latest deal in the pharmaceutical space, Germany-based Bayer
is acquiring Merck's consumer care business, which includes well-known
brands like Claritin, Afrin and Coppertone, for $14.2 billion.
The
deal means Bayer will get a list of well-known U.S. brands that sell at
pharmacies, grocery stores and other retail outlets with the hope of
expanding sales to a broader global clientele. While these Merck brands
are already sold around the world, the bulk of sales are still
U.S.-based.
No comments:
Post a Comment